Clinical Trials Browser

INDUSTRY × Prostatic Neoplasms × BID protein, human × Clear all

NCT04421222 2025-02-28

EPI-7386

Phase 1 Terminated

Prostatic Neoplasms

NCT00751205 2014-10-28

Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)

Phase 2 Completed

GenitourinaryGynecologic

Ovarian Neoplasms, Peripheral Nervous System Diseases, Prostatic Neoplasms